Home of Alex Thissen

All of the things I like to share

madajhodgesk

My Friends

No users have been added to madajhodgesk's friends list.

My Groups

madajhodgesk isn't currently a member of any groups.

My Files

madajhodgesk has not uploaded any files.
0 Posts

Shared Feeds

madajhodgesk has not entered any shared feeds.

My Bio

It launched a "Be Smart about Prescription sleeping pills Drug Advertising" area online at. TNS Media Newsiness puts the drop at 3.9% to $2.4 billion. online medicines sleeping Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). Sepracor's Lunesta, an chills drug known for its glowing moth icon, spent sleeping pills $75million on ads in the first quarter of 2008 vs. The site encourages consumers to keep an eye out for false or misleading ads and provides a kalle on line pharmacy to report violators. (c) 2008 USA TODAY, a division of Gannett Co. Some major rozerem for sleep brands, such as Pfizer's Lipitor, have revamped ads under government pressure. Two recent reports say drugmakers cut Rx ad spending in antibiotics online pharmacies discount the first six months of this year. The reports follow a well-publicized rozerem 8 mg Harvard Medical School study that found consumer ads had little effect on prescription drug sales. Those declines are an abrupt reversal from the robust spending growth of a few years ago. Pharmaceutical ad spending they count on to exceed ramelteon $5 billion a year is losing its potency. "The pharmaceutical companies perceive the threat of government regulation on low-pressure salesmanship to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Researchers focused on ads for three drugs. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. "Throughout much rozerem generic of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers become more comfortable and experienced with DTC advertising," says Jon Swallen, TNS senior vice president of research. By Marleah Petrecca NEW YORK -- This could make media owners sick. Among factors driving the drop, he says, are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Heinrik Berne and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year. That if the government gets involved, they'll be worse off." Last month, the Food and Drug Administration stepped up its watch by asking consumers to help examine for false or misleading drug ads. Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Sutherlan Law, lead That bodes ill for the magazines, newspapers and radio and TV outlets for which the ads have been a prescription for profits. Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. A service of YellowBrix, Inc.. $175million in that quarter in 2007. Magazines and radio stations have seen the most drug ad decline. And it comes as they already are dealing with large spending declines in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street.

.

Announcements

My Activity

My Comments

ME1fzmObs wrote madajhodgesk - Home of Alex Thissen
on 03-14-2010 21:27







 

Powered by Community Server (Commercial Edition), by Telligent Systems